Qube Research & Technologies LTD Lifevantage Corp Transaction History
Qube Research & Technologies LTD
- $62.3 Billion
- Q2 2024
A detailed history of Qube Research & Technologies LTD transactions in Lifevantage Corp stock. As of the latest transaction made, Qube Research & Technologies LTD holds 1 shares of LFVN stock, worth $10. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1
Previous 388
99.74%
Holding current value
$10
Previous $2,000
100.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding LFVN
# of Institutions
56Shares Held
2.98MCall Options Held
0Put Options Held
0-
Jim Simons Renaissance Technologies LLC | New York, Ny855KShares$8.8 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA498KShares$5.13 Million0.0% of portfolio
-
Dimensional Fund Advisors LP Austin, TX310KShares$3.19 Million0.0% of portfolio
-
Acadian Asset Management LLC Boston, MA224KShares$2.3 Million0.0% of portfolio
-
Black Rock Inc. New York, NY201KShares$2.07 Million0.0% of portfolio
About Lifevantage Corp
- Ticker LFVN
- Exchange NASDAQ
- Sector Consumer Defensive
- Industry Packaged Foods
- Shares Outstandng 12,560,000
- Market Cap $129M
- Description
- LifeVantage Corporation engages in the identification, research, development, formulation, sale, and distribution of nutrigenomic activators, dietary supplements, nootropics, pre- and pro-biotics, weight management, skin and hair care products, bath and body, and targeted relief products. The company offers Protandim, a line of scientifically va...